Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1959 1
1970 2
1973 2
1976 1
1979 1
1981 2
1982 6
1983 2
1984 4
1985 1
1986 3
1987 3
1988 5
1989 10
1990 3
1991 11
1992 9
1993 9
1994 10
1995 5
1996 12
1997 11
1998 15
1999 25
2000 24
2001 27
2002 25
2003 30
2004 42
2005 43
2006 48
2007 68
2008 90
2009 72
2010 91
2011 108
2012 135
2013 121
2014 148
2015 175
2016 166
2017 157
2018 206
2019 241
2020 104
Text availability
Article attribute
Article type
Publication date

Search Results

2,045 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Seduikyte
Page 1
Empagliflozin as add-on to linagliptin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a 52-week, randomized, placebo-controlled trial.
Kawamori R, Haneda M, Suzaki K, Cheng G, Shiki K, Miyamoto Y, Solimando F, Lee C, Lee J, George J. Kawamori R, et al. Diabetes Obes Metab. 2018 Sep;20(9):2200-2209. doi: 10.1111/dom.13352. Epub 2018 Jun 1. Diabetes Obes Metab. 2018. PMID: 29766636 Free PMC article. Clinical Trial.
Patients with HbA1c 7.5%-10.0% after ≥16 weeks of using Lina (pre-enrolment or during a 16-week, open-label period) and 2 weeks of using placebo (Plc) for Empa/Lina 10/5, plus Lina, were randomized (2:1) to once-daily Empa/Lina 10/5 (n = 182) or Plc/ …
Patients with HbA1c 7.5%-10.0% after ≥16 weeks of using Lina (pre-enrolment or during a 16-week, open-label period) and 2 weeks of us …
Novel LinA type 3 δ-hexachlorocyclohexane dehydrochlorinase.
Shrivastava N, Prokop Z, Kumar A. Shrivastava N, et al. Appl Environ Microbiol. 2015 Nov;81(21):7553-9. doi: 10.1128/AEM.01683-15. Epub 2015 Aug 21. Appl Environ Microbiol. 2015. PMID: 26296732 Free PMC article.
Its deduced primary structure in the region spanning amino acid residues 1 to 147 of the protein exhibits 17 and 12 differences from LinA type 1 and LinA type 2, respectively. In addition, the residues GIHFAPS, present at the region spanning residues 148 to 154 in b …
Its deduced primary structure in the region spanning amino acid residues 1 to 147 of the protein exhibits 17 and 12 differences from LinA …
LiNa(5)Mo(9)O(30).
Hamza H, Ennajeh I, Zid MF, Driss A. Hamza H, et al. Acta Crystallogr Sect E Struct Rep Online. 2012 Nov 1;68(Pt 11):i80-i81. doi: 10.1107/S1600536812041876. Epub 2012 Oct 13. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 23284311 Free PMC article.
The tite compound, lithium penta-sodium nona-molybdate, LiNa(5)Mo(9)O(30), was synthesized by solid-state reaction. The three-dimensional [Mo(9)O(30)](6-) framework is built up from MoO(6) octa-hedra and MoO(5) bipyramids, linked together by edges and corners. ...
The tite compound, lithium penta-sodium nona-molybdate, LiNa(5)Mo(9)O(30), was synthesized by solid-state reaction. The three-dimensi …
Linagliptin as add-on to empagliflozin in a fixed-dose combination in Japanese patients with type 2 diabetes: Glycaemic efficacy and safety profile in a two-part, randomized, placebo-controlled trial.
Kaku K, Haneda M, Tanaka Y, Lee G, Shiki K, Miyamoto Y, Solimando F, Lee J, Lee C, George J. Kaku K, et al. Diabetes Obes Metab. 2019 Jan;21(1):136-145. doi: 10.1111/dom.13496. Epub 2018 Sep 6. Diabetes Obes Metab. 2019. PMID: 30091172 Free PMC article. Clinical Trial.
Patients with HbA1c 7.5-10.0% were randomized (1:1) to a 24-week regimen of once-daily Empa/Lina 10/5 (n = 107) or Empa/Plc 10/5 (n = 108) in Part A, or to Empa/Lina 25/5 (n = 116) or Empa/Plc 25/5 (n = 116) in Part B, with a 28-week extension period in Part B. RESU …
Patients with HbA1c 7.5-10.0% were randomized (1:1) to a 24-week regimen of once-daily Empa/Lina 10/5 (n = 107) or Empa/Plc 10/5 (n = …
Lina Stern (1878-1968): an outstanding scientist of her time.
Sarikcioglu L. Sarikcioglu L. Childs Nerv Syst. 2017 Jul;33(7):1027-1029. doi: 10.1007/s00381-017-3392-3. Epub 2017 Apr 1. Childs Nerv Syst. 2017. PMID: 28365910 No abstract available.
Important amino acid residues of hexachlorocyclohexane dehydrochlorinases (LinA) for enantioselective transformation of hexachlorocyclohexane isomers.
Shrivastava N, Macwan AS, Kohler HE, Kumar A. Shrivastava N, et al. Biodegradation. 2017 Jun;28(2-3):171-180. doi: 10.1007/s10532-017-9786-9. Epub 2017 Mar 1. Biodegradation. 2017. PMID: 28251436 Free PMC article.
LinA-type1 and LinA-type2 are two well-characterized variants of the enzyme 'hexachlorocyclohexane (HCH)-dehydrochlorinase'. ...Thus, the residues K20, L96, A131, and T133 in LinA-type1 and the residues Q20, C96, G131, and M133 in LinA-type 2 appear to …
LinA-type1 and LinA-type2 are two well-characterized variants of the enzyme 'hexachlorocyclohexane (HCH)-dehydrochlorinase'. . …
Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production In Vitro.
Nonfoux L, Chiaruzzi M, Badiou C, Baude J, Tristan A, Thioulouse J, Muller D, Prigent-Combaret C, Lina G. Nonfoux L, et al. Appl Environ Microbiol. 2018 May 31;84(12):e00351-18. doi: 10.1128/AEM.00351-18. Print 2018 Jun 15. Appl Environ Microbiol. 2018. PMID: 29678918 Free PMC article.
Crystal structure of the hexachlorocyclohexane dehydrochlorinase (LinA-type2): mutational analysis, thermostability and enantioselectivity.
Macwan AS, Kukshal V, Srivastava N, Javed S, Kumar A, Ramachandran R. Macwan AS, et al. PLoS One. 2012;7(11):e50373. doi: 10.1371/journal.pone.0050373. Epub 2012 Nov 27. PLoS One. 2012. PMID: 23209726 Free PMC article.
The structure was solved by molecular replacement using the co-ordinates of LinA-type1 that exhibits mesophile-like properties. Structural comparison of LinA-type2 and -type1 proteins suggests that thermostability of LinA-type2 might partly arise due to prese …
The structure was solved by molecular replacement using the co-ordinates of LinA-type1 that exhibits mesophile-like properties. Struc …
DPP-4 inhibition by linagliptin prevents cardiac dysfunction and inflammation by targeting the Nlrp3/ASC inflammasome.
Birnbaum Y, Tran D, Bajaj M, Ye Y. Birnbaum Y, et al. Basic Res Cardiol. 2019 Aug 6;114(5):35. doi: 10.1007/s00395-019-0743-0. Basic Res Cardiol. 2019. PMID: 31388770
Lina and EX limited IS in both the WT and the db/db mice. Lina and EX equally improved ejection fraction in both the WT and the db/db mice. mRNA levels of ASC, NALP3, IL-1β, IL-6, Collagen-1, and Collagen-3 were higher in the db/db mice than in the WT mice. ...Li …
Lina and EX limited IS in both the WT and the db/db mice. Lina and EX equally improved ejection fraction in both the WT and th …
New insights into coagulase-negative staphylococci.
Lina G. Lina G. Clin Microbiol Infect. 2019 Sep;25(9):1063. doi: 10.1016/j.cmi.2019.06.006. Epub 2019 Jun 15. Clin Microbiol Infect. 2019. PMID: 31212074 No abstract available.
2,045 results
Jump to page
Feedback